Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study of pemetrexed and gemcitabine chemotherapy given once every 14 days
to patients with advanced stage non-small cell lung cancer. This treatment is for patients
that have not received any prior chemotherapy treatment for lung cancer. The primary goal is
to find out if the tumor gets smaller or disappears with this treatment.